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A B S T R A C T
The internet-based intervention Deprexis® has proven to be effective in improving overall depression severity.
The current pragmatic randomized controlled trial included 1013 participants with mild to moderate sympto-
matology and aimed to identify the symptom-specific effects of the internet-based intervention Deprexis (in-
tervention group) in comparison to care as usual (control group). All participants -in both conditions- were
permitted to use any type of treatment. Of the nine considered symptoms (assessed with the Patient Health
Questionnaire), seven showed larger improvements in the intervention condition relative to care as usual (effect
sizes ranging from 0.15 to 0.31). No significant differences were found for the two other symptoms. In a next
step, a network was estimated including treatment condition as well as changes in all nine symptoms. The
resulting network suggests that four of the seven identified symptom-specific effects were direct, whereas the
three other symptom-specific effects were indirect and could be explained by effects on other symptoms. Lastly,
exploratory analyses showed that the intervention was more effective in improving overall depression severity
for participants with higher scores on those four symptoms that were directly affected by the intervention;
consequently, the network estimation techniques showed potential in precision psychiatry.
Funding
This work was supported by the German Federal Ministry of Health
(grant number II A 5-2512 FSB 052) and the Netherlands Organization
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1. Introduction
1.1. The importance of considering individual symptoms
Randomized controlled trials (RCTs) provide the best evidence
about the general effectiveness of treatments. They have demonstrated,
for example, that pharmacological (e.g., Mulrow et al., 2000),
psychotherapeutic (e.g., Churchill et al., 2001) as well as internet-based
(e.g., Karyotaki et al., 2017) interventions are effective in improving
overall depression severity in various groups of participants. Although
these findings are highly valuable, it is important to note that measures
such as overall depression severity might not do justice to the diversity
of depressive symptomatology.
An extensive review on this topic, for example, showed that in-
dividual depressive symptoms differ in various important dimensions,
such as underlying biology and impact on impairment (Fried & Nesse,
2015a). In addition, the multifactorial structures of several commonly
used depression scales are not stable over time and, consequently, scale
scores may be inappropriate as outcome measures (Fried et al., 2016).
Recent RCTs on the effectiveness of various depression treatments have
also shown that individual depressive symptoms differ in their response
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to treatment (Bekhuis et al., 2018; Blanken et al., 2019; Boschloo et al.,
2019; Hieronymus, Emilsson, Nilsson, & Eriksson, 2016). It may,
therefore, be valuable to consider individual symptoms as a more spe-
cific assessment of effectiveness, especially given the differences in
clinical relevance across symptoms; for example, an effect on ‘suicidal
thoughts’ or ‘depressed mood’ might be considered more relevant than
an effect on ‘concentration problems’.
1.2. The potential of network estimation techniques
Another advantage of a focus on individual symptoms is that it can
help in identifying patterns in the diversity of symptomatology. An
analysis of, for example, 3703 depressed patients revealed as many as
1030 unique symptom profiles based on combinations of depressive
symptoms (Fried & Nesse, 2015b). Network estimation techniques
specifically focus on individual symptoms and the complex patterns in
which they typically co-occur; see, for example, Fried et al. (2017) for a
review of empirical network studies and Epskamp, Borsboom, and Fried
(2018) for a tutorial paper on network analyses.
Network estimation techniques can also be helpful in shedding light
on the diversity of symptom-specific changes, for example, in response
to treatment (Bekhuis et al., 2018; Blanken et al., 2019; Boschloo et al.,
2019). Our study on the efficacy of antidepressant medication over
cognitive behavioral therapy (Boschloo et al., 2019) showed that anti-
depressant medication was directly related to larger improvements in
four symptoms, indicating that these larger improvements were in-
dependent of changes in other symptoms. The effect on one symptom
was indirect, indicating that the larger improvement in that symptom
was only present in patients who also experienced larger improvements
in other symptoms. No significant differences between the two treat-
ment conditions were found for another twelve symptoms.
The results of the network estimation techniques might also help in
identifying participants who, based on their baseline symptomatology,
would benefit more from a particular treatment relative to another.
That is, participants primarily suffering from symptoms that are directly
affected by the treatment would -by definition- benefit more from that
treatment than participants primarily suffering from other symptoms.
Network estimation techniques may therefore also show potential in
“precision psychiatry”.
1.3. Current study
This article focuses on the importance of considering individual
symptoms as a more specific assessment of treatment effectiveness. In
addition, we aim to explore the potential of network estimation tech-
niques in shedding light on the complex patterns in which symptoms
respond to treatment and in identifying participants who will benefit
most from the intervention. We decided to focus on an internet-based
intervention, as such treatments have great potential given their low-
threshold accessibility, high anonymity, easy translatability and limited
costs. The specific intervention, “Deprexis”, has already proven to be
effective for different outcomes and in different settings (e.g., Klein
et al., 2016; Meyer et al., 2015; Schröder et al., 2014).
Data were derived from a large pragmatic RCT (N=1013) con-
sidering the effectiveness of “Deprexis” relative to care as usual in
participants with mild to moderate depressive symptomatology (Klein
et al., 2016). This intervention has already proven to be successful in
improving overall depression severity in this particular group (i.e., ef-
fect size within the small to moderate range) and we wanted to extend
these findings by considering its effects on nine depressive symptoms as
assessed with the Patient Health Questionnaire (PHQ-9; Kroenke,
Spitzer, & Williams, 2001). Secondly, we wanted to demonstrate the
potential of network estimation techniques in shedding light on the
diversity of symptom-specific changes and to examine direct and in-
direct symptom-specific effects. Lastly, we wanted to illustrate the po-
tential of these network estimation techniques in identifying
participants who, based on their baseline symptomatology, were likely
to benefit more from the intervention relative to care as usual; that is,
participants primarily suffering from symptoms that were directly af-
fected by the internet-based intervention would -by definition- benefit
more from the intervention than other participants.
2. Method
2.1. Trial design
This was a pragmatic multicenter trial, conducted at five sites in
Germany, which was controlled, randomized and assessor-blinded. For
the present study, we used data of the assessments conducted at base-
line and at a 3-month post-assessment (the primary outcome of the
trial); the monthly assessments following the post-assessment (i.e., 4–12
months of follow-up) were not used in the current study. The trial ad-
heres to the guidelines of the CONSORT statement and its adaptation
for internet interventions, CONSORTEHEALTH. It was approved by the
Ethics Committee of the German Psychological Association (SM
04_2012) and registered in the ClinicalTrials.gov database
(NCT01636752). The study protocol has been published (Klein et al.,
2013) and no changes have been made to the protocol after study
commencement. As extensive information on the trial design, partici-
pants and intervention has already been described in the study protocol
(Klein et al., 2013) and the publication with the main findings (Klein
et al., 2016), we only briefly describe these topics here.
2.2. Participants
This study included 1013 adults (18–65 years) with mild to mod-
erate depressive symptoms, as assessed with the Patient Health
Questionnaire (PHQ-9; Kroenke et al., 2001). The PHQ-9 is a self-report
questionnaire comprising nine items on the frequency of the nine
symptoms of a DSM-IV major depressive disorder. All individual items
are scored from 0 (never) to 3 (almost every day) and mild to moderate
depressive symptomatology is defined as a total score between 5 and
14. Additional inclusion criteria were having internet-access and being
able to communicate in German. Participants with acute suicidality
(based on a structured assessment of current suicidal ideation and past
suicide attempts; Hamilton, 1960; Sheehan et al., 1998; Posner et al.,
2011) or a lifetime diagnosis of bipolar disorder or schizophrenia
(based on the Mini International Neuropsychiatric Interview, MINI;
Sheehan et al., 1998) were excluded. Neither a diagnosis of a depressive
disorder nor current treatment was an inclusion criterion.
Participants were recruited via multiple settings, including inpatient
and outpatient medical and psychological clinics, online forums for
depression, health insurance companies and the media. Participants
received extensive information about the aims and procedure of the
study and were informed that they could withdraw at any time without
having to disclose reasons. All participants provided (online) informed
consent before the baseline assessment.
Of the 1013 included participants, 504 (49.8%) were randomly
assigned to care as usual and 509 (50.2%) to the internet-based inter-
vention (192 received the unguided and 317 received the guided ver-
sion; stratification based on baseline severity of depressive symptoma-
tology, see section 2.3). In total, 794 (78.4%) had complete post-
assessment data on all individual depressive symptoms, with no dif-
ference between the care as usual versus intervention condition (79.2%
versus 77.6%, p=0.55; based on Chi-square test) and the unguided
versus guided internet-intervention (80.2% versus 76.0%, p=0.27;
based on Chi-square test). Participants with missing post-assessment
data did not differ from participants with complete data in overall de-
pression severity, any of the nine individual depressive symptoms or
any of the sociodemographics at baseline, except for age (41.1 versus
43.3 years, p=0 .008; based on independent samples t-tests).
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2.3. Treatment conditions
Participants were randomized equally (1:1) to either the internet-
based intervention or care as usual (i.e., control) condition. Participants
in both conditions were permitted to use any type of treatment (e.g.,
inpatient or outpatient psychiatric treatment), both before and during
the study, and the investigators did not try to influence this.
Participants in the intervention condition received access to the inter-
vention in addition to their usual care. Participants in the care as usual
condition received only care as usual and were offered access to the
intervention after twelve months.
The internet-based intervention is a 12-week program (Deprexis)
comprising ten modules on topics that are broadly consistent with CBT
and one additional summary module (see Meyer et al., 2009 and
Berger, Hammerli, Gubser, Andersson, & Caspar, 2011 for full details of
the intervention). These modules were based on strategies such as 1)
Behavioral Activation, 2) Cognitive Modification, 3) Mindfulness and
Acceptance, 4) Interpersonal Skills, 5) Relaxation, Physical Exercise and
Lifestyle modification, 6) Problem Solving, 7) Childhood Experiences
and Early Schemas, 8) Positive Psychology Intervention, 9) Dreamwork
and Emotion-Focused Intervention, 10) Psychoeducation. The program
is interactive by engaging the participant in exercises and continuously
eliciting feedback in order to tailor subsequent content. It also contains
audio recordings, worksheets, summary sheets and brief automatic
daily messages, delivered either by e-mail or SMS. All participants who
did not log in to the program within two weeks after randomization
received an e-mail describing the login procedure once again.
The internet-based intervention can be used with or without gui-
dance by a clinician (Berger et al., 2011). Participants with mild de-
pressive symptomatology (PHQ-score between 5 and 9) at baseline re-
ceived the unguided version of the intervention, whereas participants
with moderate symptomatology (PHQ-score between 10 and 14) re-
ceived the guided version of the intervention because of safety and
efficacy considerations. Participants receiving the guided version of the
intervention were actively contacted once a week by a trained e-mail
supporter who provided brief feedback based on the participant's use of
the program over the previous week. Participants could respond to
these messages or contact the e-mail supporter themselves. The primary
goal of the e-mail guidance was to motivate participants to engage with
the program. More details on the training and supervision for e-mail
supporters are provided in the study protocol (Klein et al., 2013).
2.4. Outcome measures
The nine individual depressive symptoms were assessed with sepa-
rate items of the PHQ-9 (Kroenke et al., 2001), both before treatment
and at a 3-month post-assessment. All items assess the frequency of
symptoms during the past two weeks and are scored from 0 (never) to 3
(almost every day). We chose the PHQ-9 for the assessment of in-
dividual symptoms, as the sum score of this questionnaire was the
primary outcome in the original publication on the general effective-
ness of the intervention (Klein et al., 2016).
2.5. Data analysis
All non-network analyses were performed using SPSS (version 24).
First, baseline characteristics were compared between participants in
the intervention versus care as usual condition using Χ2 statistics for
categorical variables (i.e., gender) and independent samples t-tests for
continuous variables (i.e., age, overall depression severity and in-
dividual depressive symptom scores). Paired t-tests were performed to
compare the post-assessment symptom scores to baseline symptom
scores for the two conditions separately. Independent samples t-tests
were performed to determine whether change scores of individual
symptoms differed between the two treatment conditions. Given the
exploratory nature of the study, no adjustments for multiple
comparisons were made and, instead, all individual p-values were re-
ported. A p-value of < 0 .05 was considered significant.
All network analyses were performed using statistical software R
(version 3.3.3). First, we examined whether the internet-based inter-
vention had direct or indirect effects on changes in individual symp-
toms. For this purpose, a network including treatment condition and
changes in individual depressive symptoms was estimated with package
mgm (Haslbeck & Waldorp, 2019) using a mixed graphical model. This
package uses the glmnet package (Friedman, Hastie, & Tibshirani, 2010)
to fit penalized generalized linear models to perform neighborhood
selection (Meinshausen & Bühlmann, 2006). Package qgraph (Epskamp,
Cramer, Waldorp, Schmittmann, & Borsboom, 2012) was used to vi-
sualize the network. The resulting network shows the direct and in-
direct connections between treatment condition and changes in all in-
dividual symptoms. As a sensitivity analysis, we tested whether the
internet-based intervention affected the patterns in which changes in
symptoms were related. A network including changes in all nine de-
pressive symptoms was estimated with l1-regularized partial correla-
tions for the care as usual condition and intervention condition sepa-
rately; the package NetworkComparisonTest (Van Borkulo, 2019) was
used to test whether the networks differed.
In addition, we wanted to illustrate the potential of network esti-
mation techniques in identifying those participants who, based on their
baseline symptomatology, were likely to benefit more from the inter-
vention relative to care as usual. Participants primarily suffering from
symptoms that were directly affected by the internet-based intervention
would -by definition- benefit more from the intervention than other
participants. To illustrate and test this, we calculated a severity measure
based on the weighted sum of all nine symptoms, in which the
weighting was based on the direct effects of the intervention on in-
dividual symptoms. We expected that the effect of the intervention on
overall depression severity would be larger in participants with higher
scores on this weighted severity measure; effect modification was ex-
plicitly tested using linear regression analyses and a p-value of < 0.10
was considered significant.
Lastly, a set of sensitivity analyses was performed to explore po-
tential differences in results between the unguided versus guided ver-
sion of the internet-based intervention. Participants with mild depres-
sive symptoms received the unguided version and participants with
moderate depressive symptoms received the guided version, and the
analyses were repeated for the two groups separately.
3. Results
3.1. Sample characteristics
Of the 794 included participants who had complete post-assessment
data on all individual symptoms (i.e., the sample for our analyses; see
section 2.2), 399 received care as usual and 395 the intervention. No
differences between conditions were found for any of the socio-
demographics, any of the treatment types before and during the study,
overall depression severity or any of the nine individual depressive
symptoms at baseline (Table 1).
3.2. Symptom-specific effectiveness of the internet-based intervention
Although overall depression severity improved significantly in both
conditions (both p < 0.001), this improvement was significantly larger
for the intervention than for care as usual (Table 2; Cohen's d=0.38).
All individual depressive symptoms also improved significantly in both
conditions, except for ‘suicidal thoughts’ in the care as usual condition
(deterioration of 0.03 points, p= 0.30). Of the nine symptoms, seven
showed significantly larger improvements in the intervention condition
relative to care as usual (Table 2; Cohen's d ranging from 0.15 for
‘suicidal thoughts’ to 0.32 for ‘concentration problems’). No significant
differences were found for the other two symptoms (‘poor appetite or
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overeating’: p=0 .06, ‘psychomotor retardation/agitation’: p=0 .19).
3.3. The potential of network estimation techniques
In both conditions, individual participants experienced substantially
different changes in their precise symptomatology; we observed 367 (of
399; 92.0%) unique combinations of the nine symptom change scores in
the care as usual condition and 361 (of 395; 91.4%) unique combina-
tions in the intervention condition. Here, we demonstrate the potential
of network estimation techniques in shedding light on the diversity of
symptom-specific changes in response to treatment and in identifying
participants who would likely benefit more from the intervention re-
lative to care as usual.
To provide more information about the direct and indirect
symptom-specific effects of the intervention over care as usual, a
network was estimated including treatment condition and changes in
individual symptoms (Fig. 1; see Supplemental Table S1 for the un-
derlying matrix with connection strengths). The network suggests that
four of the seven previously identified symptom-specific effects were, at
least partly, direct; suggesting that the larger improvements in ‘feeling
guilty/worthless’, ‘concentration problems’, ‘sleeping problems’ and
‘tired or having little energy’ in response to the intervention were in-
dependent of changes in other symptoms. The previously identified
symptom-specific effects on ‘little interest or pleasure’, ‘feeling de-
pressed/hopeless’ and ‘suicidal thoughts’ appear to be indirect, sug-
gesting that the larger improvements in these symptoms were only
present in participants who reported larger improvements in the four
symptoms that were directly affected by the intervention. It is im-
portant to note that also the four effects on ‘feeling guilty/worthless’,
‘concentration problems’, ‘sleeping problems’ and ‘tired or having little
energy’ could be partly indirect.
As a sensitivity analysis, we tested whether the internet-based in-
tervention affected the patterns in which changes in symptoms were
related. The two networks including changes in all nine depressive
symptoms did not differ for the care as usual versus intervention con-
dition (Supplemental Fig. S1; p= 0.76 for global connectivity, and
Holm-Bonferroni corrected p-values were all ≥0.32 for individual
connections).
Participants primarily suffering from symptoms that are directly
affected by the treatment benefit -by definition- more from that treat-
ment than participants primarily suffering from other symptoms. To
illustrate this, a severity indicator was calculated in which scores on
baseline symptoms were summed and weighted based on the magni-
tude of the direct effects of the intervention. As the internet-based in-
tervention was only directly related to ‘feeling guilty/worthless’ (con-
nection strength: 0.13), ‘concentration problems’ (connection strength:
0.12), ‘tired or having little energy’ (connection strength: 0.11) and
‘sleeping problems’ (connection strength: 0.02), the severity indicator
was only based on these four symptoms. As expected, the effect of the
intervention on the change in overall depression severity depended on
this baseline severity indicator (effect-modification: p=0 .02); the in-
tervention was more effective across participants with increasing levels
on this baseline severity indicator (Fig. 2; effect sizes ranging from 0.15
for the first quintile to 0.50 for the last quintile). As a comparison,
another severity measure was calculated based on the simple sum of the
five symptoms that were not directly affected by the intervention; as
expected, the effectiveness of the intervention did not depend on this
baseline severity measure (effect-modification: p=0.81).
3.4. Unguided and guided version of the internet-based intervention
To explore whether the reported effects for the overall internet-
based intervention were driven by the effects of either the unguided or







mean (sd)/% mean (sd)/% p
Sociodemographics
Female gender 67.9% 69.9% 0.55
Age at baseline 43.0 (10.7) 43.7 (10.9) 0.32
Treatment in the 6 months prior to baseline







Treatment between baseline and post-assessment







Antidepressant medication 51.3% 48.9% 0.50
Baseline depressive symptomatology
Overall depression severity 10.3 (2.5) 10.2 (2.4) 0.63
Individual symptoms
Little interest/pleasure 1.4 (0.7) 1.4 (0.6) 0.93
Feeling depressed/hopeless 1.3 (0.6) 1.2 (0.6) 0.27
Sleeping problems 1.6 (0.9) 1.5 (0.9) 0.69
Tired or having little energy 1.7 (0.8) 1.7 (0.7) 0.85
Poor appetite or overeating 1.1 (0.9) 1.1 (0.8) 0.97
Feeling guilty/worthless 1.3 (0.8) 1.3 (0.8) 0.66
Concentration problems 1.2 (0.7) 1.2 (0.7) 0.22
Psychomotor agitation/
retardation
0.5 (0.7) 0.5 (0.6) 0.17
Suicidal thoughts 0.2 (0.4) 0.2 (0.4) 1.00
Table 2
Improvements in depressive symptomatology in the intervention compared to care as usual condition.
Care as usual (N=399) Intervention (N=395) p Cohen's d
mean (sd) mean (sd)
Overall depression severity 1.22 (4.31) 2.83 (4.10) <0.001 0.38
Individual symptoms
Little interest/pleasure 0.21 (0.84) 0.36 (0.81) 0.01 0.18
Feeling depressed/hopeless 0.19 (0.81) 0.33 (0.80) 0.01 0.17
Sleeping problems 0.11 (1.08) 0.32 (0.98) 0.004 0.20
Tired or having little energy 0.16 (0.96) 0.45 (0.95) <0.001 0.30
Poor appetite or overeating 0.10 (0.96) 0.23 (0.93) 0.06 0.14
Feeling guilty/worthless 0.27 (0.87) 0.54 (0.86) <0.001 0.31
Concentration problems 0.07 (0.88) 0.34 (0.83) <0.001 0.32
Psychomotor agitation/retardation 0.14 (0.78) 0.21 (0.70) 0.19 0.09
Suicidal thoughts −0.03 (0.53) 0.05 (0.53) 0.03 0.15
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performed in which results were stratified and compared for patients
with mild depressive symptomatology (receiving the unguided version
of the intervention or care as usual) or moderate depressive sympto-
matology (receiving the guided version of the intervention or care as
usual). First, we determined the symptom-specific effectiveness of the
two versions and found that the guided version had more significant
effects than the unguided version (six versus three symptom-specific
effects; see Supplemental Tables S2 and S3); effect sizes were, however,
largely comparable for the two versions of the intervention. Second, we
estimated a network including the treatment condition and changes in
individual symptoms for patients with mild and moderate symptoma-
tology separately and found that the networks did not differ (p=0.45
for global connectivity, and Holm-Bonferroni corrected p-values were
all ≥0.72 for individual connections). Lastly, we explored whether the
weighted severity indicator based on the four symptoms that were di-
rectly affected by the intervention (in the primary analyses) was helpful
in identifying those participants who would benefit more from either
the unguided or the guided version of the intervention than from care
as usual; both versions were more effective for participants with in-
creasing levels on this severity indicator (effect modification: both were
p=0 .09). The effectiveness of both the unguided and the guided ver-
sion of the intervention were independent of the baseline severity in-
dicator based on the five symptoms that were not directly affected by
the intervention (effect-modification: p=0 .69 for the unguided and
p=0 .53 for the guided version).
4. Discussion
4.1. Principal findings
This article focused on the importance of considering individual
symptoms as a more specific assessment of treatment effectiveness as
well as the potential of network estimation techniques in shedding light
on the symptom-specific changes in response to treatment and in
identifying participants who will benefit more from the one treatment
relative to the other. We found that seven of the nine symptoms showed
larger improvements in the internet-based intervention relative to the
care as usual condition, and one was borderline significant. The net-
work estimation techniques further suggested that the internet-based
intervention had a direct effect on four symptoms and the effects on the
other three symptoms were, thus, indirect. In addition, we illustrated
the potential of these network estimation techniques in identifying
participants who were likely to benefit more from the intervention re-
lative to care as usual; as expected, the intervention was more effective
for participants suffering from those symptoms that were directly af-
fected by the intervention.
4.2. Symptom-specific effectiveness of the internet-based intervention
Previous studies have already demonstrated that the internet-based
intervention Deprexis is superior to care as usual in improving overall
depression severity after three and six months (Klein et al., 2016) as
well as over the course of one year (Klein et al., 2017). Klein et al.
(2016), for example, showed that the internet-based intervention was
effective in improving overall depression severity after three months,
with an effect size within the small to moderate range. The current
study is an important extension, as it demonstrated that the interven-
tion had an effect on seven depressive symptoms after three months,
including symptoms that are highly clinically relevant such as ‘feeling
depressed/hopeless’ and ‘suicidal thoughts’. It is important to note that
the seven symptoms differed in their response to the intervention, with
effect sizes ranging from 0.15 for ‘suicidal thoughts’ to 0.32 for ‘con-
centration problems’. No effects were found for ‘poor appetite or
overeating’ (borderline significant) and ‘psychomotor agitation/re-
tardation’ (not significant). As studies on other treatment types have
also observed substantial differences across symptom-specific effects,
we believe that considering individual symptoms as a more detailed
assessment of effectiveness would be an important step forward; espe-
cially, since it could inform participants more precisely about the pre-
ferred treatment option.
Fig. 1. Network structure including both treatment
condition and improvements in individual depressive
symptoms.
Black lines indicate direct connections between
treatment condition and improvements in individual
symptoms (all effects of the intervention are posi-
tive). Blue lines represent positive connections be-
tween improvements in symptoms, red lines re-
present negative connections between improvements
in symptoms (not present in this network). Thicker
lines represent stronger connections. Symptoms that
showed larger improvements in the intervention re-
lative to care as usual in the general analysis (see
Table 2) are colored dark grey, while symptoms
showing similar responses to the conditions are co-
lored light grey. The network is presented at
γ=0.25. (For interpretation of the references to
color in this figure legend, the reader is referred to
the Web version of this article.)
Fig. 2. Improvements in overall depression severity in the care as usual (CAU)
versus intervention (INT) condition, stratified for participants with increasing
scores on a baseline severity indicator (weighted).
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4.3. The potential of network estimation techniques
Fried and Nesse (2015b) previously showed that patients with the
same diagnosis of major depressive disorder differed substantially in
their exact symptomatology. The response of individual symptoms to
the internet-based intervention as well as care as usual was also diverse,
as we found that more than 90% of participants in each condition were
unique in their combination of changes in individual symptoms. In-
formation about this diversity is largely lost when symptoms are com-
bined into scale scores of overall severity.
Network estimation techniques showed that the internet-based in-
tervention was, at least partly, directly related to larger improvements
in ‘feeling guilty/worthless’, ‘concentration problems’, ‘sleeping pro-
blems’ and ‘tired or having little energy’, indicating that these larger
improvements were independent of changes in other symptoms. This
could be explained by the content of the intervention; the modules on
Cognitive Modification as well as Mindfulness and Acceptance may
have resulted in decreases in ‘feeling guilty/worthless’, whereas the
module on Relaxation, Physical Exercise and Lifestyle modification may
have been beneficial for ‘sleeping problems’, ‘tired or having little en-
ergy’ and ‘concentration problems’. The effects on ‘little interest or
pleasure’ and ‘feeling depressed/hopeless’ and ‘suicidal thoughts’ were
indirect, suggesting that these larger improvements were only present
in participants who also reported larger improvements in the four
symptoms that were directly affected by the intervention.
The results from these network estimation techniques have potential
in generating hypotheses regarding the working mechanisms of treat-
ment, as they may suggest a causal chain in which changes in specific
symptoms result in changes in specific other symptoms. For example,
we found that an improvement in ‘feeling guilty/worthless’, which was
directly affected by the internet-based intervention, was related to an
improvement in ‘feeling depressed/hopeless’ and ‘suicidal thoughts’,
suggesting that improved self-worth may have resulted in a decrease in
depressed mood and suicidality. Other potential causal chains are that,
for example, an improvement in ‘sleeping problems’ may cause an
improvement in ‘being tired or having little energy’, and an improve-
ment in ‘being tired or having little energy’ may cause an improvement
in ‘little interest or pleasure’ as well as ‘feeling depressed/hopeless’.
It is, however, important to note that changes in symptoms were
assessed simultaneously and that the temporal relationships between
them remain unknown. In addition, the network estimation techniques
are not intended to formally test for mediation. For example, the reg-
ularization techniques set weak connections to zero and, consequently,
conservatively identify the most relevant connections in the network. A
weak direct connection between the internet-based intervention and,
for example, an improvement in ‘feeling depressed/hopeless’ or ‘sui-
cidal thoughts’ could be set to zero and thus, in reality, this effect would
not be fully indirect. To examine whether the hypothesized causal
chains are really present and, more fundamentally, to determine whe-
ther a network model or another type of model (e.g. a common cause or
hybrid model) best describes the dynamics of symptoms, it would be
more appropriate to use data from the experience sampling method
including large numbers of assessments with short time intervals. In
addition, it would be interesting to include comorbid symptomatology
(e.g. anxiety symptoms), other outcomes (e.g., quality of life) or other
factors that are believed to play a role in the working mechanisms of
treatment (e.g., social support) (see paragraph 4.4 for a more thorough
discussion of this topic).
As individual depressive symptoms differed in their response to the
internet-based intervention, we expected that participants primarily
suffering from symptoms that were directly affected by the intervention
would benefit more from the intervention relative to care as usual. This
was also illustrated by our findings; participants who scored higher on
the symptoms ‘feeling guilty/worthless’, ‘concentration problems’,
‘sleeping problems’ and ‘tired or having little energy’ benefitted most
from the intervention (effect sizes ranging from 0.41 to 0.50). In
contrast, no significant difference in the effectiveness of the interven-
tion was found for participants scoring the lowest on these four
symptoms. These findings are an important step forward in “precision
psychiatry”, as they can inform participants more precisely about the
effectiveness of the intervention based on their baseline symptoma-
tology.
4.4. Strengths and weaknesses of the study and suggestions for further
research
Strength of the current study is that we considered individual de-
pressive symptoms as a more detailed assessment of the effectiveness of
the internet-based intervention relative to care as usual. It is, however,
important to note that much is still unclear about the reliability and
validity of assessing individual symptoms. An advantage of the PHQ-9
is that all items have the same answering categories and that the sen-
sitivity to detect changes in symptom frequency is thus, at least in
theory, comparable across symptoms. Previous studies on the symptom-
specific efficacy of other treatment types often used the Hamilton
Depression Rating Scale with its varying response categories and, in
general, larger effects were observed for symptoms with more response
categories (Boschloo et al., 2019; Hieronymus et al., 2016).
A weakness of the PHQ-9 is that opposite symptoms are aggregated
into one item; for example, poor appetite and overeating are combined
into a single item and the same is true for psychomotor agitation and
retardation as well as hypersomnia and insomnia. Aggregation of these
symptoms may have distorted the results regarding the symptom-spe-
cific effects of the intervention and could provide an alternative ex-
planation for not finding significant treatment effects on ‘poor appetite
and overeating’ and ‘psychomotor agitation and retardation’. It may
also have impacted the estimated networks. Previous network studies
showed that disaggregated symptoms were connected to different
symptoms (Boschloo et al., 2015); for example, psychomotor agitation
was connected to insomnia but not hypersomnia, whereas psychomotor
retardation was connected to hypersomnia and not insomnia. There-
fore, we would like to advice other researchers to consider dis-
aggregated symptoms in their research on treatment effectiveness.
Another weakness of the PHQ-9 is that it focuses exclusively on the
nine depressive symptoms and we believe that it would be valuable to
adopt a transdiagnostic approach by also considering comorbid symp-
tomatology (Boschloo, 2018). Previous studies on the symptom-specific
efficacy of other depression treatments observed, for example, addi-
tional effects on specific anxiety and somatic symptoms (Bekhuis et al.,
2018; Boschloo et al., 2019; Hieronymus et al., 2016), and also other
symptomatology, such as alcohol problems, might be valuable to con-
sider. In addition, it would be interesting to include other clinically
relevant outcomes (e.g., aspects of daily functioning or quality of life),
as all this information combined may help in making a deliberate de-
cision about starting a particular treatment or not. In future research on
the potential working mechanisms of treatment, it would be interesting
to not only focus on symptomatology or other outcomes but also to
consider factors that have been hypothesized to play a role in the
working mechanisms of treatment (e.g., locus of control or social sup-
port).
A limitation of this study is that the analyses are based on the
participants with complete data at baseline and 3-month post-assess-
ment and not the intention-to-treat sample. It is, however, unlikely that
this has substantially affected the results, as the observed effectiveness
of the intervention in improving overall depression severity is highly
comparable for the two sample (i.e., effect size of 0.38 in our sample
versus 0.39 in the intention-to-treat sample as published by Klein et al.,
2016). In addition, none of the nine individual depressive symptoms at
baseline were a significant predictor of missing data at the post-as-
sessment.
Lastly, it is important to emphasize that our findings are based on
one randomized controlled trial. Replication studies in similar as well as
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different settings are needed to prove the validity of our findings. In
addition, it is important to emphasize that the current study is based on
a pragmatic RCT aiming to examine the effectiveness of the internet-
based intervention in a real-world situation. Such a design is not ap-
propriate for determining the working mechanisms of treatment, as it
does not adequately control for potential confounding factors such as
using other types of treatment before or during the study or differences
between the unguided and guided version of the intervention.
5. Conclusion
The current study demonstrated the importance of considering in-
dividual symptoms as a more specific assessment of treatment effec-
tiveness. We found that individual depressive symptoms differed con-
siderably in their response to the internet-based intervention Deprexis
relative to care as usual; seven symptoms showed larger improvements
in the internet-based intervention (effect sizes ranging from 0.15 to
0.31), whereas no significant differences were found for the two other
symptoms. We also demonstrated the potential of network estimation
techniques in shedding light on the symptom-specific changes in re-
sponse to treatment and in identifying participants who are likely to
benefit more from the intervention than from care as usual. Four of the
seven symptom-specific effects were, at least partly, direct, whereas the
effects on the other three symptoms were, thus, indirect. As expected,
participants with higher scores on those symptoms that were directly
affected by the intervention improved most from the internet-based
intervention relative to care as usual (effect sizes as high as 0.50),
whereas no difference in effectiveness was found for participants
scoring the lowest on these four symptoms.
Appendix A. Supplementary data
Supplementary data to this article can be found online at https://
doi.org/10.1016/j.brat.2019.103440.
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